M. Stanley

The In-Vitro Pharmacology Of PF-4348235 At Recombinant Receptors - A Novel Inhaled Dual Antimuscarinic/Beta2 Adrenoceptor Agonist

M. Trevethick, E. Stuart, M. Yeadon, 2011, ATS 2011.

The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.

M. Trevethick, S. Patel, S. Summerhill, 2011, Pulmonary pharmacology & therapeutics.

Synthesis, In Vitro and In Vivo Evaluation of 18F-labeled PET Ligands for Imaging the Vesicular Acetylcholine Transporter

R. Mach, L. Jones, S. Efange, 2009 .

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome

J. Hipp, M. Rafii, P. Fontoura, 2022, Journal of neurodevelopmental disorders.

Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder

M. Rafii, S. Jafarpour, J. Santoro, 2023, Research square.

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome

J. Hipp, M. Rafii, P. Fontoura, 2022, Journal of Neurodevelopmental Disorders.